How cytisine and estrogen protect brain cells in Parkinson's disease
Identification of mechanisms by which cytisine and estrogen inhibit ER stress and exert neuroprotection in Parkinson's disease
This study is looking at how two compounds, cytisine and estrogen, might help protect brain cells from damage in people with Parkinson's disease by reducing stress in important cell structures, with the hope of finding new treatments that could improve lives.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas A&m University Health Science Ctr NIH-funded |
| Lab location | 1 site (College Station, United States) |
| Project ID | NIH-10792592 on NIH RePORTER |
What this research studies
This research investigates how the compounds cytisine and estrogen can help protect brain cells from damage in Parkinson's disease by reducing stress in the endoplasmic reticulum, a critical cellular structure. The study focuses on understanding the mechanisms behind this protective effect, particularly how these compounds influence specific proteins involved in cell survival and death. By using preclinical models that mimic Parkinson's disease, the researchers aim to identify effective neuroprotective strategies that could lead to new treatments for patients. The goal is to translate these findings into potential therapies that can improve patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Parkinson's disease, particularly those who may benefit from new therapeutic approaches.
Not a fit: Patients with Parkinson's disease who are not responsive to neuroprotective strategies or those with advanced stages of the disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new neuroprotective treatments for Parkinson's disease, potentially slowing disease progression and improving quality of life for patients.
How similar studies have performed: Previous research has shown promise in using similar approaches to target neuroprotection in neurodegenerative diseases, indicating potential for success in this area.
Where this research is happening
College Station, United States
- Texas A&m University Health Science Ctr — College Station, United States (Active)
Researchers
- Principal investigator: Srinivasan, Rahul — Texas A&m University Health Science Ctr
- Study coordinator: Srinivasan, Rahul
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.